

CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
You can purchase shares of CareDx (NASDAQ:CDNA) through any online brokerage.
Other companies in CareDx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
CareDx has a consensus price target of $42.33.
The stock price for CareDx (NASDAQ: CDNA) is $78.49 last updated November 6, 2026 at 7:28 PM EST.
There are no upcoming dividends for CareDx.
CareDx does not have any upcoming earnings scheduled.
There is no upcoming split for CareDx.
CareDx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services,...